Skip to content
Modus Therapeutics
Developing therapeutics to restore heathy blood flow for patients with debilitating diseases
Modus Therapeutics
  • Home
  • About
  • Sevuparin
  • SIRS
  • Sepsis
  • Team
  • Investors
  • News
  • Home
  • About
  • Sevuparin
  • SIRS
  • Sepsis
  • Team
  • Investors
  • News

Claes Lindblad

Read Bio ›

Claes Lindblad
Chief Financial Officer

Claes Lindblad is Chief Financial Officer at Modus. He has over 20 years of pharmaceutical and medtech experience in a range of sales and marketing, operational and financial roles. Before joining Modus Therapeutics, he was the CFO of OssDsign, where he led the finance and administrative functions of the company and played a key role in the company’ IPO on Nasdaq First North, as well as acquisition activities. Claes has a multi-disciplinary background with qualifications in both chemical, and administrative sciences from the university of Karlstad.

Close

CONTACT US


Modus Therapeutics AB

Olof Palmes gata 29 IV, 11122 Stockholm, Sweden
CIN 556669-2199
info@modustx.com
Phone: +468 501 370 00
© 2021. Modus Therapeutics AB. All rights reserved.   Privacy & Terms of Use
Go to Top
This web site uses cookies so that we can serve you better. OkPrivacy policy